HGF and ovarian carcinoma: However, in 2004, Rasola A. et al. unexpectedly revealed that pre-treatment with HGF enhances the apoptotic response of human ovarian cancer cells to very low doses of paclitaxel (PTX) and cisplatin (CDDP)[14].